A prospective non-interventional post-authorization safety study (PASS), designed as a disease registry of patients with transfusion dependent IPSS low or intermediate-1-risk myelodysplastic syndromes (MDS) and isolated del(5q) (CC-5013-MDS-010) First published 14/10/2014 Last updated 02/07/2024 EU PAS number:EUPAS7412 Study Finalised